The role of glucose homeostasis and glucocorticoid signalling for the development of relevant hepatic in vitro models for toxicology, drug metabolism and energy metabolism studies

被引：0
|
作者：
Saraiva Rodrigues, J. [1 ]
Faria-Pereira, A. [2 ]
Camoes, S. P. [1 ]
Serras, A. S. [1 ]
Morais, V. A. [2 ]
Ruas, J. L. [3 ]
Miranda, J. P. [1 ]
机构：
[1] Univ Lisbon, Res Inst Med iMed ULisboa, Fac Pharm, Lisbon, Portugal
[2] Univ Lisbon, Inst Med Mol Joao Lobo Antunes, Fac Med, Lisbon, Portugal
[3] Karolinska Inst, Dept Physiol & Pharmacol, Biomedicum, Stockholm, Sweden
来源：
TOXICOLOGY LETTERS | 2023年 / 384卷
关键词：
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P16-19
引用
收藏
页码：S188 / S188
页数：1
相关论文
共 40 条
  • [31] The Role of GLP1-RAs in Direct Modulation of Lipid Metabolism in Hepatic Tissue as Determined Using In Vitro Models of NAFLD
    Petrovic, Ana
    Igrec, Dunja
    Rozac, Karla
    Bojanic, Kristina
    Kuna, Lucija
    Kolaric, Tea Omanovic
    Mihaljevic, Vjera
    Sikora, Renata
    Smolic, Robert
    Glasnovic, Marija
    Wu, George Y.
    Smolic, Martina
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (06) : 4544 - 4556
  • [32] Fibrosis Development Linked to Alterations in Glucose and Energy Metabolism and Prooxidant-Antioxidant Balance in Experimental Models of Liver Injury
    Semenovich, Dmitry S.
    Andrianova, Nadezda V.
    Zorova, Ljubava D.
    Pevzner, Irina B.
    Abramicheva, Polina A.
    Elchaninov, Andrey V.
    Markova, Olga V.
    Petrukhina, Aleksandra S.
    Zorov, Dmitry B.
    Plotnikov, Egor Y.
    ANTIOXIDANTS, 2023, 12 (08)
  • [33] Docosahexaenoic acid supplementation during porcine oocyte in vitro maturation improves oocyte quality and embryonic development by enhancing the homeostasis of energy metabolism
    Lee, Yongjin
    Shim, Joohyun
    Ko, Nayoung
    Kim, Hyoung-Joo
    Kim, Jun-Hyeong
    Kim, Hyunil
    Choi, Kimyung
    THERIOGENOLOGY, 2024, 227 : 49 - 59
  • [34] Hypothalamic Protein Kinase Ikkepsilon (IKKε) has a Key Role in Energy Balance and Hepatic Glucose Metabolism in Db/Db and DIO Mice
    Weissmann, Lais
    Quaresma, Paula Gabriele Fernandes
    Santos, Andressa C.
    Pascoal, Vinicius D'Avila Bitencourt
    Katashima, Carlos Kiyoshi
    Zanotto, Tamires
    Guadagnini, Dioze
    Cendes, Iscia Lopes
    Saad, Mario J.
    Prada, Patricia O.
    DIABETES, 2012, 61 : A65 - A65
  • [35] Targeted LC-MS/MS Proteomics-Based Strategy To Characterize in Vitro Models Used in Drug Metabolism and Transport Studies
    Xu, Meijuan
    Saxena, Neha
    Vrana, Marc
    Zhang, Haeyoung
    Kumar, Vineet
    Billington, Sarah
    Khojasteh, Cyrus
    Heyward, Scott
    Unadkat, Jashvant D.
    Prasad, Bhagwat
    ANALYTICAL CHEMISTRY, 2018, 90 (20) : 11873 - 11882
  • [36] Improvement of mesenchymal stem cell differentiation into hepatocyte-like cells using 3D culture models: Potential in vitro alternatives for drug metabolism studies
    Cipriano, M.
    Freyer, N.
    Knoespel, F.
    Camoes, S.
    Santos, J. M.
    Cruz, H.
    Oliveira, N.
    Castro, M.
    Zeilinger, K.
    Miranda, J. P.
    TOXICOLOGY LETTERS, 2015, 238 (02) : S187 - S187
  • [37] Paradoxical Role of Cytochrome P450 3A in the Bioactivation and Clinical Effects of Levo-α-AcetylmethadolImportance of Clinical Investigations to Validate In Vitro Drug Metabolism Studies
    Evan D. Kharasch
    Dale Whittington
    Christine Hoffer
    Kevin Krudys
    Keith Craig
    Paolo Vicini
    Pam Sheffels
    Bojan Lalovic
    Clinical Pharmacokinetics, 2005, 44 : 731 - 751
  • [38] Paradoxical role of cytochrome P450 3A in the bioactivation and clinical effects of levo-α-acetylmethadol -: Importance of clinical investigations to validate in vitro drug metabolism studies
    Kharasch, ED
    Whittington, D
    Hoffer, C
    Krudys, K
    Craig, K
    Vicini, P
    Sheffels, P
    Lalovic, B
    CLINICAL PHARMACOKINETICS, 2005, 44 (07) : 731 - 751
  • [39] Characterisation of some cytotoxic endpoints using rat liver and HepG2 spheroids as in vitro models and their application in hepatotoxicity studies. I. Glucose metabolism and enzyme release as cytotoxic markers
    Xu, JS
    Ma, MW
    Purcell, WM
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2003, 189 (02) : 100 - 111
  • [40] Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines
    Brandon, EFA
    Bosch, TM
    Deenen, MJ
    Levink, R
    van der Wal, E
    van Meerveld, JBM
    Bijl, M
    Beijnen, JH
    Schellens, JHM
    Meijerman, I
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2006, 211 (01) : 1 - 10
1234